COMSTECH-NTD NETWORK JOINT LECTURE SERIES: Seventh Lecture. ‘NEW ANTILEISHMANIAL DRUGS : FROM DISCOVERY TO DELIVERY’
Prof. Dr. Bartira Rossi Bergmann
Instituto de Biofísica Carlos Chagas Filho
Universidade Federal do Rio de Janeiro – Brasil
Date: 21st July, 2022
Time: 4 pm Pakistan Standard Time
Our Programme: NTDs (neglected tropical diseases) are a major health and economic burden in Organisation of Islamic Cooperation (OIC) member states. The control and elimination of NTDs requires both a scale-up and integration of global mass treatment programs, along with new tools and technologies to tackle these diseases. COMSTECH, in collaboration with A Global Network for Neglected Tropical Diseases (known as the NTD Network, https://ntd-network.org/ , is launching a virtual lecture series. for researchers across the Moslem world and beyond. Our programme draws upon expertise from both networks, and offers opportunities to gain or enhance researcher knowledge, skills and connections, all of which help to grow our shared global capacity to tackle these rapidly growing NTDs.
- The NTD Network, funded by UKRI’s Global Challenges Research Fund (GCRF), is a consortium of academic researchers from South America, Asia, and the UK, seeking new therapeutic solutions to leishmaniasis and Chagas disease
- Both COMSTECH and the NTD Network aim to promote global scientific cooperation and build researcher capacity to find new and better therapeutic solutions for NTDs
This online programme is the one of many COMSTECH-NTD Network joint activities via the COMSTECH platform.
Target Audience: This webinar is open to academics, scientists and the general public from all OIC member states. The content is most relevant to scientists interested in NTDs research, and specialized in Microbiology, Genetics, Genomics, Molecular Biology, Molecular Medicine, and Pathology.
Bartira obtained her BSc in Biomedicine from the University of São Paulo – Brazil. MSc in Medical Parasitology from LSHTM – University of London and PhD in Biology from Brunel University – UK on chemotherapy and immunology of leishmaniasis and African trypanosomiasis. Then, she got a research post at FIOCRUZ (Brazil) focused in clinical leishmaniasis and post-doc in University of Toronto – Canada on tolerogenic vaccination in transplantation later applied with success to leishmaniasis. Presently, she holds a professorship post in UFRJ where she is a member of the animal ethics committee, and the Head of the Leishmaniasis Group working in mucosal vaccines and drug release systems for leishmaniasis. In the industry area, Bartira has developed projects with pharmas like SANOFI and GSK, and founded the LeishNano startup for the nano and micro- technological development of novel vaccines and drugs
Register with us to attend this meeting:
• Register at: https://forms.gle/x442UhDxYdAcPWdS6
Contact us for further details: